-
1دورية أكاديمية
المؤلفون: Jiang, Jue, Hu, Yu-Chi, Liu, Chia-Ju, Halpenny, Darragh, Hellmann, Matthew D., Deasy, Joseph O., Mageras, Gig, Veeraraghavan, Harini
المصدر: IEEE Transactions on Medical Imaging; Jan2019, Vol. 38 Issue 1, p134-144, 11p
مصطلحات موضوعية: COMPUTED tomography, IMAGE segmentation, MAGNETIC resonance imaging, CANCER treatment, DIAGNOSTIC imaging
-
2دورية أكاديمية
المؤلفون: Arbour, Kathryn C., Naidoo, Jarushka, Steele, Keith E., Ni, Ai, Moreira, Andre L., Rekhtman, Natasha, Robbins, Paul B., Karakunnel, Joyson, Rimner, Andreas, Huang, James, Riely, Gregory J., Hellmann, Matthew D.
المصدر: PLoS ONE; 8/3/2017, Vol. 12 Issue 8, p1-11, 11p
مصطلحات موضوعية: EPITHELIAL cells, IMMUNOLOGY, THYMOMA, EPITHELIAL tumors, IMMUNOTHERAPY
-
3دورية أكاديمية
المؤلفون: Snyder, Alexandra, Nathanson, Tavi, Funt, Samuel A., Ahuja, Arun, Buros Novik, Jacqueline, Hellmann, Matthew D., Chang, Eliza, Aksoy, Bulent Arman, Al-Ahmadie, Hikmat, Yusko, Erik, Vignali, Marissa, Benzeno, Sharon, Boyd, Mariel, Moran, Meredith, Iyer, Gopa, Robins, Harlan S., Mardis, Elaine R., Merghoub, Taha, Hammerbacher, Jeff, Rosenberg, Jonathan E.
المصدر: PLoS Medicine; 5/26/2017, Vol. 14 Issue 5, p1-24, 24p, 1 Chart, 4 Graphs
مصطلحات موضوعية: LIGANDS (Biochemistry), CANCER chemotherapy, TRANSITIONAL cell carcinoma, ANTIGENS, T cell receptors, CANCER prevention, ANTINEOPLASTIC agents, CANCER, CELL receptors, CLINICAL trials, COMPARATIVE studies, EPITHELIUM, GENOMES, RESEARCH methodology, MEDICAL cooperation, MONOCLONAL antibodies, RESEARCH, RESEARCH funding, URINARY organs, EVALUATION research, SEQUENCE analysis, PHARMACODYNAMICS, TUMORS
-
4دورية أكاديمية
المؤلفون: Hellmann, Matthew D1 hellmanm@mskcc.org, Rizvi, Naiyer A1, Goldman, Jonathan W2, Gettinger, Scott N3, Borghaei, Hossein4, Brahmer, Julie R5, Ready, Neal E6, Gerber, David E7, Chow, Laura Q8, Juergens, Rosalyn A9, Shepherd, Frances A10, Laurie, Scott A11, Geese, William J12, Agrawal, Shruti12, Young, Tina C12, Li, Xuemei12, Antonia, Scott J13
المصدر: Lancet Oncology. Jan2017, Vol. 18 Issue 1, p31-41. 11p.
مصطلحات موضوعية: *NON-small-cell lung carcinoma, *CANCER treatment, *IPILIMUMAB, *CANCER chemotherapy, *COMBINATION drug therapy, *COHORT analysis, *CLINICAL trials, *THERAPEUTICS, *ANTINEOPLASTIC agents, *ADENOCARCINOMA, *COMPARATIVE studies, *LONGITUDINAL method, *LUNG cancer, *LUNG tumors, *RESEARCH methodology, *MEDICAL cooperation, *MONOCLONAL antibodies, *PROGNOSIS, *RESEARCH, *RESEARCH funding, *STATISTICAL sampling, *SQUAMOUS cell carcinoma, *SURVIVAL, *TUMOR classification, *EVALUATION research, *RANDOMIZED controlled trials
-
5دورية أكاديمية
المؤلفون: Hellmann, Matthew D., Friedman, Claire F., Wolchok, Jedd D.
المصدر: Advances in Immunology; Apr2016, Vol. 130, p251-277, 27p
مصطلحات موضوعية: CANCER immunotherapy, T cells, CANCER patients, CANCER treatment, PROGRAMMED cell death 1 receptors, CYTOTOXIC T lymphocyte-associated molecule-4, THERAPEUTICS
-
6دورية أكاديمية
المؤلفون: Rizvi, Naiyer A.1,2,3, Hellmann, Matthew D.1,2, Snyder, Alexandra1,2,4, Kvistborg, Pia5, Makarov, Vladimir4, Havel, Jonathan J.4, Lee, William, Jianda Yuan6, Wong, Phillip6, Ho, Teresa S.6, Miller, Martin L.7, Rekhtman, Natasha8, Moreira, Andre L.8, Ibrahim, Fawzia1, Bruggeman, Cameron9, Gasmi, Billel10, Zappasodi, Roberta10, Yuka Maeda10, Sander, Chris7, Garon, Edward B.11
المصدر: Science. 4/3/2015, Vol. 348 Issue 6230, p124-128. 5p.
مصطلحات موضوعية: *PROGRAMMED cell death 1 receptors, *NON-small-cell lung carcinoma, *CANCER immunology, *T cells, *TUMOR treatment, *CANCER treatment, *LUNG cancer & genetics, *GENETIC mutation, *GENETICS
-
7دورية أكاديمية
المؤلفون: Hellmann, Matthew D.1 hellmanm@mskcc.org, Callahan, Margaret K.1, Awad, Mark M.2, Calvo, Emiliano3, Ascierto, Paolo A.4, Atmaca, Akin5, Rizvi, Naiyer A.6, Hirsch, Fred R.7, Selvaggi, Giovanni8, Szustakowski, Joseph D.9, Sasson, Ariella9, Golhar, Ryan9, Vitazka, Patrik9, Chang, Han9, Geese, William J.9, Antonia, Scott J.10
المصدر: Cancer Cell. May2018, Vol. 33 Issue 5, p853-861.e4. 1p.
مصطلحات موضوعية: *IPILIMUMAB, *CANCER treatment, *SMALL cell lung cancer, *DRUG efficacy, *CLINICAL trials, *THERAPEUTICS, TUMOR genetics
-
8دورية أكاديمية
المؤلفون: Hellmann, Matthew D.1,2,3,4 hellmanm@mskcc.org, Nathanson, Tavi5, Rizvi, Hira3, Creelan, Benjamin C.6, Sanchez-Vega, Francisco7,8, Ahuja, Arun5, Ni, Ai9, Novik, Jacki B.5, Mangarin, Levi M.B.10, Abu-Akeel, Mohsen10, Liu, Cailian10, Sauter, Jennifer L.11, Rekhtman, Natasha11, Chang, Eliza5, Callahan, Margaret K.1,2,4, Chaft, Jamie E.1,2,3, Voss, Martin H.1,2, Tenet, Megan3, Li, Xue-Mei12, Covello, Kelly12
المصدر: Cancer Cell. May2018, Vol. 33 Issue 5, p843-852.e4. 1p.
مصطلحات موضوعية: *CANCER treatment, *CANCER immunotherapy, *NON-small-cell lung carcinoma, *CYTOTOXIC T lymphocyte-associated molecule-4, *PROGRESSION-free survival, *GENETICS
-
9دورية أكاديمية
المؤلفون: Miao, Diana1,2, Margolis, Claire A.1,2, Wenhua Gao1, Voss, Martin H.3,4, Li, Wei5, Martini, Dylan J.1, Norton, Craig1, Bossé, Dominick1, Wankowicz, Stephanie M.1,2, Cullen, Dana6, Horak, Christine6, Wind-Rotolo, Megan6, Tracy, Adam2, Giannakis, Marios1,2, Stephen Hodi, Frank1, Drake, Charles G.7, Ball, Mark W.8, Allaf, Mohamad E.8, Snyder, Alexandra3,9, Hellmann, Matthew D.3,4
المصدر: Science. 2/16/2018, Vol. 359 Issue 6377, p801-806. 6p. 4 Diagrams.
مصطلحات موضوعية: *CANCER treatment, *RENAL cell carcinoma, *PROGRAMMED cell death 1 receptors, *GENOMICS, *GENE expression profiling, *IMMUNOTHERAPY